In a global study of myasthenia gravis, an autoimmune disease that causes muscle weakness and fatigue, researchers found that surgical removal of an organ called the thymus reduced patients’ weakness, and their need for immunosuppressive drugs. The study, published in the New England Journal of Medicine, was partially funded by the National Institutes of Health

“Our results support the idea that thymectomy is a valid treatment option for a major form of myasthenia gravis,” said Gil Wolfe, M.D., Professor and Irvin and Rosemary Smith Chair of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, and a leader of the study.

Related posts:

  1. Medicare Card, Sepsis study comparing three treatment methods shows same survival rate Medicare Card, Sepsis study comparing three treatment methods shows same survival rate...
  2. Medicare Card, Study points to possible treatment for lethal pediatric brain cancer Medicare Card, Study points to possible treatment for lethal pediatric brain cancer...
  3. NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute […]...
  4. Medicare Card, Paramedics may be first line of treatment for stroke Medicare Card, Paramedics may be first line of treatment for stroke...
  5. Program to Enhance Communication of Life-sustaining Treatment Preferences Associated with Closer Adherence to a Person’s Wishes when Compared with Traditional Practices, Finds NIH-Supported Study A program in which individuals used a standardized form signed by a physician to communicate their end-of-life care preferences on issues such as levels of medical intervention and tube feeding lead to significantly better adherence to treatment preferences than more traditional methods of communication, according to a new study....
  6. Medicare, After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels. In a six-month study, a new treatment strategy provided the same benefits as the current standard of care used for more than 40 years but required less […]...
  7. Medicare Card, NIH mouse study finds gut microorganisms may determine cancer treatment outcome An unhealthy gut microbiome may limit treatment effectiveness.  An intact population of microorganisms that derive food and benefit from other organisms living in the intestine is required for optimal response to cancer therapy, according to a mouse study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and their […]...
  8. Funded study finds more precise way to estimate kidney function Measuring creatinine and cystatin C — two markers for chronic kidney disease (CKD) — more precisely estimates kidney function than either marker alone, according to a study funded by the National Institutes of Health. Results appear in the July 5 issue of the New England Journal of Medicine....
  9. Medicare Card, NIH-funded study points way forward for retinal disease gene therapy Medicare Card, NIH-funded study points way forward for retinal disease gene therapy...
  10. Medicare Card, NIH study shows people with serious mental illnesses can lose weight Medicare Card, NIH study shows people with serious mental illnesses can lose weight...
  11. Stanford researcher to speak at NIH on the role of neuroimaging in understanding pain Sean Mackey, M.D., Ph.D., chief of the Pain Management Division and associate professor of anesthesia and pain management at the Stanford University School of Medicine, Stanford, Calif., will be the featured speaker for the third annual Stephen E. Straus Distinguished Lecture in the Science of Complementary and Alternative Medicine....
  12. Medicare Card, Virginia Tech Researcher to speak at NIH on cancer and natural products Medicare Card, Virginia Tech Researcher to speak at NIH on cancer and natural products...
  13. Medicare Card, NIH-funded trial launched to assess experimental TB drug Medicare Card, NIH-funded trial launched to assess experimental TB drug...
  14. Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
  15. Medicare Card, NIH launches trial for rare degenerative muscle disease treatment Medicare Card, NIH launches trial for rare degenerative muscle disease treatment...